Bech-Bruun advises Ferring Pharmaceuticals on new domicile
Bech-Bruun has advised Ferring Pharmaceuticals on the establishment of a new company to build Ferring’s new domicile in the Oresund Region and on the purchase agreement.
The medico giant Ferring Pharmaceuticals has decided to build a new domicile in the Scanport area on the outskirts of Copenhagen.
The company has outgrown its current 16,000 m2 domicile and has signed a building contract for 30,000 m2 in the Scanport area. Offices and research facilities will occupy 24,000 m2, accommodating for 600 employees. The remaining 6,000 m2 will be parking facilities.
The Scanport location meets all the company’s logistics requirements. Its close proximity to Copenhagen Airport, the Oresund Bridge Tunnel and the Copenhagen Metro offers Ferring Pharmaceuticals' employees from both the Danish and the Swedish sides of the Oresund Region equal and easy access to work. The new domicile is expected to be completed in 2016.
Bech-Bruun has advised Ferring Pharmaceuticals on the establishment of Soundport A/S, which is to build the new domicile, and assisted the company in the purchase agreement negotiations with the Skanska Group.